Selenium and cancer risk: Wide-angled Mendelian randomization analysis.

Authors:
Yuan S; Mason AM; Carter P; Vithayathil M; Kar S and 2 more

Journal:
Int J Cancer

Publication Year: 2021

DOI:
10.1002/ijc.33902

PMCID:
PMC7613914

PMID:
34910310

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int J Cancer

Abbreviation: Int J Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Chronic acidosis rewires cancer cell metabolism through PPARα signaling.
Rolver MG; Holland LKK; Ponniah M and 11 more (2023) - Transparency Score: 4/6
A defect of amphiregulin release predicted longer survival independently of YAP expression in patie…
Maille E; Levallet J; Dubois F and 17 more (2022) - Transparency Score: 3/6
Agricultural activities and risk of central nervous system tumors among French farm managers: Resul…
Petit P; Gandon G; Chabardès S and 1 more (2022) - Transparency Score: 3/6
A hybrid design for dose-finding oncology clinical trials.
Liao JJZ; Zhou F; Zhou H and 3 more (2022) - Transparency Score: 3/6
A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia g…
Faber MT; Frederiksen K; Palefsky JM and 1 more (2022) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest: All authors declare no conflict of interest."

Evidence found in paper:

"Funding information Our study was funded by the Swedish Cancer Society (Cancerfonden) and supported by the National Institute for Health Research Cambridge Biomedical Research Centre (BRC-1215-20 014). Siddhartha Kar is supported by United Kingdom Research and Innovation Future Leaders Fellowship (MR/T043202/1). Amy M. Mason is supported by EC-Innovative Medicines Initiative (BigData@Heart). Stephen Burgess is supported by Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (204 623/Z/16/Z)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025